NSE filing, NSE: DIVINEHIRA. Summary written from the filing by ALFA Finder's alert engine.
Divine Hira Jewellers Ltd: key numbers
- Share price
- ₹93.00
- Market cap
- ₹364.0 Cr
- Revenue (annual)
- ₹883.8 Cr
- Net profit (annual)
- ₹7.13 Cr
- P/E (TTM)
- 51.1×Sector 49.0×
- Promoter holding
- 72.70%+0.00% QoQ
- FII holding
- 0.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Divine Hira Jewellers Ltd
All →Divine Hira Jewellers Management Change
Divine Hira Jewellers Limited announced the change in designation for two directors and the re-appointment of its secretarial auditor.
Divine Hira Jewellers Annual General Meeting
Divine Hira Jewellers Limited conducted its 4th Annual General Meeting on September 04, 2026, through video conferencing to discuss standard shareholder business resolutions.
Divine Hira Jewellers Annual General Meeting
Divine Hira Jewellers Limited has scheduled its 04th Annual General Meeting for September 04, 2026. The company also announced relevant cut-off dates for shareholder voting.
Divine Hira Jewellers Q1 FY27 Results: Net Profit ₹0.9 Cr
Divine Hira Jewellers Ltd reported revenue from operations of ₹195.4 Cr and net profit of ₹0.9 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.9 Cr
Divine Hira Jewellers Management Change
Jai Dilip Shrimankar has resigned as the Company Secretary and Compliance Officer of Divine Hira Jewellers Limited, effective from August 01, 2026.
Divine Hira Jewellers Merger & Restructuring Worth ₹1 Cr
Divine Hira Jewellers Limited incorporated a new wholly-owned subsidiary, TAARIS JEWELS LIMITED, with a capital subscription of ₹1 Crore.
- Value
- ₹1.00 Cr
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.